FDA Investigator

Linda Galindo

Latest inspection on record: Placentia, United States, June 2026 · records back to 2021

Medical Devices & Rad HealthHuman DrugsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 37 inspections across 37 sites are on record.
  • 91 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-01.

At a glance

Inspections

37

Sites

37

Observations

91

Career since

May 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Bioplate Inc1 Jun 2026Medical Devices & Rad HealthOn file
Boston Scientific Neuromodulation Corporation8 Apr 2026Medical Devices & Rad HealthOn file
Medrange Corporation24 Feb 2026Medical Devices & Rad Health
Therapak Corporation12 Feb 2026Medical Devices & Rad HealthOn file
Osseofuse International Inc.7 Jan 2026Medical Devices & Rad HealthOn file

Sites inspected

Bioplate IncPlacentia, United States1 insp.
Boston Scientific Neuromodulation CorporationValencia, United States1 insp.
Medrange CorporationBrea, United States1 insp.
Therapak CorporationClaremont, United States1 insp.
Osseofuse International Inc.Las Vegas, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Jordan I Abel2 shared
Janet Pulver2 shared
Cheron M Portee2 shared
Ronda R Loyd Jones2 shared
Juanj Wu1 shared
Andrace Deyampert1 shared
Joanne M Schlossin1 shared

Full investigator report

Get the verbatim findings behind Linda Galindo's 91 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators